Type 1 diabetes trials in France

In France 42 Also abroad 537

42 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Real-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
Where
Bron, Paris
People
60 worldwide
Run by
Sanofi
See details and how to joinNCT07457580
Phase 3Taking people
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
Where
Bron, Corbeil Essonnes Cedex, Lille Cedex, Marseille, Paris, Toulouse Cedex 9
Age
1 year to 35 years
People
150 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222137 · EU 2025-521797-34-00
Phase 3Taking people
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
Where
Bouches-du-Rhône, Corbeil Essonnes Cedex, Isère, Lille Cedex, Paris, Rhône, Toulouse Cedex 9
Age
1 year to 35 years
People
300 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07222332 · EU 2025-522170-36-00
No phaseTaking people
Continuous Monitoring of Plantar Temperature Variations Using Connected Insoles and a Mobile Application for Diabetic Foot.
Where
Lille, Montpellier
Age
18 years and over
People
60
Run by
Solsius
See details and how to joinNCT07910721
No phaseTaking people
Study of High Density Lipoprotein Function in Type 1 Diabetic Patients With Nephropathy
Where
Dijon
Age
18 years and over
People
200
Run by
Centre Hospitalier Universitaire Dijon
See details and how to joinNCT03512132
Phase 3Taking people
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Where
Bobigny, Colmar Cedex, Dijon, Lyon, Paris, Pessac, Pierre-Bénite, Thionville, Toulouse Cedex 9, Vénissieux
Age
18 years and over
People
2,500 worldwide
Run by
AstraZeneca
See details and how to joinNCT07784725 · EU 2025-523379-41-00
No phaseTaking people
Crosstalk Between Mucosal-Associated Invariant T (MAIT) Cells and the Gut Microbiota and Mucosa in the Development of Type 1 Diabetes in Children
Where
Antony, Paris
Age
12 months to 15 years
People
180
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT05054361
Phase 2/3Not yet taking people in France
Verapamil In Preclinical Type 1 Diabetes
Where
Paris
Age
7 years to 45 years
People
50
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07880769 · EU 2025-524318-27-00
No phaseTaking people
The Real-World Control-IQ Glycemic Control and Quality of Life Study in Type 1 Diabetes in France
Where
Agen, Angers, Bron, Dijon, Lyon, Mainvilliers, Marseille, Meaux, Metz, Montpellier, Nice, Nîmes, Palavas-les-Flots, Paris, Périgueux, Saint-Cyr-sur-Loire, Strasbourg, Toulouse, Tours
Age
6 years and over
People
350
Run by
Tandem Diabetes Care, Inc.
See details and how to joinNCT07211126
Phase 3Taking people
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Where
Bron, La Tronche, Lille, Paris, Pau, Strasbourg
Age
1 year to 25 years
People
723 worldwide
Run by
Sanofi
See details and how to joinNCT07088068
Phase 2Taking people
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Where
Paris
Age
5 years to 40 years
People
159 worldwide
Run by
SAb Biotherapeutics, Inc.
See details and how to joinNCT07187531 · EU 2025-521560-36-00
No phaseTaking people
Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Early Treatment Using an Automated Delivery System in Children With Type 1 Diabetes
Where
Paris
Age
5 years to 8 years
People
50
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT06461065
Phase 3Taking people
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Where
Bois-Guillaume, Colmar Cedex, Le Coudray, Paris, Pessac, Pierre-Bénite, Saint-Herblain, Vénissieux
Age
18 years and over
People
2,500 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07564414 · EU 2025-522488-14-00
No phaseNot yet taking people in France
Impact of Dietary Intervention Within an Interprofessional Cooperative Protocol for Prandial Insulin Dose Adjustment in People Living With Type 1 Diabetes
Where
Paris
Age
18 years to 69 years
People
163
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07846852
No phaseTaking people
A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
Where
Paris
Age
18 years to 99 years
People
24,000 worldwide
Run by
AstraZeneca
See details and how to joinNCT05663515
No phaseTaking people
Clinical Evaluation of the Medtronic Implantable Insulin Pump System (MIIPS 2020) in Adult Subjects With Type 1 Diabetes (CIP347)
Where
Bordeaux, Corbeil-Essonnes, Dijon, Lille, Marseille, Montpellier, Nancy, Paris, Strasbourg, Toulouse
Age
18 years and over
People
40 worldwide
Run by
Medtronic MiniMed, Inc.
See details and how to joinNCT06739811
No phaseNot yet taking people in France
Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before Transplantation
Where
Strasbourg
Age
18 years and over
People
25
Run by
University Hospital, Strasbourg, France
See details and how to joinNCT07812974
Phase 2Taking people
Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes
Where
Paris, Paris Cedex 13
Age
16 years to 45 years
People
24
Run by
Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT05153070 · EU 2024-514043-29-00
No phaseTaking people
Early Detection of Type 1 Diabetes
Where
Bron
Age
1 year to 18 years
People
106
Run by
Hospices Civils de Lyon
See details and how to joinNCT06984185
Phase 3Taking people
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Where
Lille Cedex, Strasbourg Cedex 2
Age
18 years to 65 years
People
57 worldwide
Run by
Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00
No phaseTaking people
INNODIA Family & Friends Early-Stage T1D Detection Protocol
Where
Angers, Bobigny, Bondy, Corbeil-Essonnes, Lyon, Nice, Paris, Vandœuvre-lès-Nancy
Age
1 year to 45 years
People
30,000 worldwide
Run by
INNODIA iVZW
See details and how to joinNCT07118098
No phaseTaking people
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
Where
Angers, Besançon, Bobigny, Bordeaux, Brest, Bron, Corbeil-Essonnes, Dijon, La Rochelle, Le Kremlin-Bicêtre, Mainvilliers, Marseille, Montpellier, Nantes, Palavas-les-Flots, Paris, Périgueux, Saint-Jean-de-Védas, Strasbourg, Tours
Age
2 years and over
People
152
Run by
Insulet Corporation
See details and how to joinNCT07317102
No phaseTaking people
Impact of the Mylife CamAPS FX System With the DEXCOM G6 Sensor on T1D Patients in France
Where
Amiens, Angers, Argenteuil, Bois-Guillaume, Bordeaux, Brest, Bron, Grenoble, La Rochelle, Lyon, Marseille, Paris, Périgueux, Poitiers, Pontoise, Toulouse, Vandœuvre-lès-Nancy, Vannes, Vantoux
People
125
Run by
mylife Diabetes Care AG
See details and how to joinNCT07048795
No phaseTaking people
Efficacy of Islet Re-transplantation After Failure of Beta-cell Replacement
Where
Montpellier
Age
18 years and over
People
20
Run by
University Hospital, Montpellier
See details and how to joinNCT07666789
No phaseTaking people
BeAT1D: Benign Autoimmunity and Type 1 Diabetes
Where
Bobigny, Bondy, Colombes, Corbeil-Essonnes, Le Chesnay, Le Kremlin-Bicêtre, Paris, Pontoise
Age
1 year and over
People
1,160
Run by
Institut National de la Santé Et de la Recherche Médicale, France
See details and how to joinNCT05139784